Free Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Brazil Up to 0.3% THC in plants authorised for medical, pharmaceutical, industrial use ...
  • Australia Parliamentary committee makes suggestions for cannabis law in NSW ...
  • Australia Greens announce Parliament will vote on cannabis legalisation this month ...
  • Texas - United States Bills introduced in Senate and House on medical cannabis expansion ...
  • Texas - United States House bill introduced to regulate hemp production and require research permit ...
  • Texas - United States House bills introduced on legalising recreational cannabis ...
  • Lithuania - Ukraine Cannabis conference focuses on fibre hemp, addressing challenges, restrictions ...
  • Czech Republic Criminal law reform approved, will relax some cannabis-related laws ...
  • New Zealand First sublingual THC/CBD spray meets Medicinal Cannabis Agency quality standard ...
  • Poland Motion for cannabis decriminalisation presented to prime minister ...
  • Belgium Health Belgium updates notified herbal products for smoking list ...
  • Portugal Infarmed withdraws several CBD products from market ...
View all

Policy and Politics

What can we learn from the distribution of brands by main product category and retailer type in the UK?

14th May 2021 - Blogs |

CBD-Intel’s new UK online report highlights a number of interesting market developments. Among them is the information that brand distribution provides. From a dominance perspective, more brands are now being listed for cosmetic than vape products. This shows how cosmetics now have more exposure to the wider population by having a more diverse range of brand offerings along with greater » Continue Reading.

Could CBD/hemp vaping equipment be exempt from the incoming rule prohibiting the mailing of e-cigarette and vaporiser-related products through the US Postal Service (USPS)?

7th May 2021 - Blogs |

Recent consultation guidance does suggest that the USPS is considering broadly exempting hemp and CBD services from the incoming rule. The guidance states: “For hemp-based products containing CBD with a THC concentration not exceeding 0.3 percent, mailers must retain, and prepare to make available upon request, records establishing compliance with all applicable federal, state, and local laws pertaining to hemp » Continue Reading.

What is the state of science behind minor cannabinoids really like?

29th April 2021 - Blogs |

Minor cannabinoids are gaining increasing interest – pushed by both slowly growing consumer awareness and companies looking to develop further revenue streams from under-utilised products. A number of claims have been made about the properties of various minor cannabinoids – some skirting dangerously close to the line of what is currently permitted and some going well over that health claims » Continue Reading.

How fast is the UK Food Standards Agency (FSA) novel food application validation process moving?

22nd April 2021 - Blogs |

It does not look like good news. The only two companies (controlling three brands that contain 23 individually listed products) included in the initial list of validated applications both say they submitted their applications to the FSA in early January. Both also are at least partly based on synthetic CBD ingredients that have successfully navigated EU novel food application initial » Continue Reading.

Is delta-8 THC really the next big thing?

14th April 2021 - Blogs |

From a consumer/market perspective, it certainly looks like delta-8 THC is the most promising minor cannabinoid. It has quickly overtaken others such as CBG and CBN in terms of general awareness and – anecdotally – in terms of interest from companies and consumers alike. The appeal appears to be that it acts as a “lighter” version of delta-9 THC – the more typical psychoactive element » Continue Reading.

What impact will the EC’s decision to permit the use of extracts from the whole plant in cosmetics have on the industry as a whole?

28th January 2021 - Blogs |

The decision – which should be noted is still only preliminary, though almost certainly to be confirmed with subsequent updating of the cosmetics ingredients (CosIng) database – should allow a wider range of cosmetic products onto the market. Exactly how much of an impact the change – when it eventually is confirmed – will make in reality largely depends on » Continue Reading.

What impact do Democrat victories in both of the Georgia senate seat elections have on chances for cannabis reform at the US federal level?

8th January 2021 - Blogs |

President elect Joe Biden still looks to be somewhat reluctant to too closely embrace cannabis reform as an issue. But effective control of the senate through victories by Raphael Warnock and Jon Ossoff in special run-off elections in the state of Georgia give Democrats 48 seats with two independents that generally vote democratic (and would certainly do so on most » Continue Reading.

How far-reaching an impact could the CJEU Kanavape decision have?

11th December 2020 - Blogs |

The Court of Justice of the European Union’s (CJEU) decision in the Kanavape case will have a tremendous impact on the CBD industry in the European Union (EU). However, the breadth of its impact is not yet fully realised. A number of things must happen beforehand and it may come down to further court rulings before a baseline level of requirements and » Continue Reading.

What impact will Black Friday sales have on the CBD sector?

27th November 2020 - Blogs |

Overall it seems the industry – particularly in Europe – is not expecting much from Black Friday sales. European companies appear to consider CBD products more as health products that are requirement purchases throughout the year as opposed to lifestyle products that might be purchased as a one off during a special sales event. The situation may be slightly different in the US where Black Friday – » Continue Reading.

How important is the CJEU decision on the Kanavape case?

20th November 2020 - Blogs |

How important is the CJEU decision on the Kanavape case?  The judgement in favour of CBD from the Courts of Justice of the European Union (CJEU) will almost certainly have significant long-term consequences for the CBD industry in Europe. It will likely influence the European Commission (EC)’s further assessment of the question of whether CBD is a narcotic. The preliminary opinion » Continue Reading.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.